CEM-CM3
| KCLB NO |
40195
|
|---|---|
| Name |
CEM-CM3
|
세포주 분양조건
서비스
수량
-
+
| Origin |
T cell; T lymphoblast
|
|---|---|
| Species |
human female, 4 years old, Caucasian
|
| Cellular morphology |
lymphoblast
|
| Growth Pattern |
suspension
|
| Histopathology |
leukemia, acute lymphoblastic
|
| D3S1358 |
15
|
|---|---|
| vWA |
18,19
|
| FGA |
23,24
|
| Amelogenin |
X
|
| TH01 |
6,7
|
| TPOX |
8
|
| CSF1P0 |
11
|
| D5S818 |
12,13
|
| D13S317 |
12
|
| D7S820 |
10,13
|
준비중입니다.
| freeze media |
RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%
|
|---|---|
| original medium |
RPMI1640 with 15 mcg/ml 8-azaguanine, 90%; heat inactivated fetal bovine serum (FBS), 10%
|
| kclb media |
Dulbecco's modified Eagle's medium, 90%; heat inactivated fetal bovine serum (FBS) 10%
|
| note |
this line was derived from CCRF-CEM by selecting for resistance to 8-azaguanine; the line has been used as a fusion partner in the production of human-human T cell hybridomas
|
|
Clin Res, 31:734A, 1983; Cathcart, M.K. and M. Murakami, Nonspecific suppression of antibody synthesis by products of human T lymphocyte hybridomas. Use of a newly selected parent fusion line. In: T cell Hybrodomas (M.J. Taussig, ed.) CRC press, Boca Raton, FL. 1985 p. 227-236; Cathcart, M.K. Human T Lymphocyte hybridomas: Production of nonspecific suppressor factors of antibody synthesis. 5th International Congress of Immunology, Kyoto, Japna, August, 1983, Abstract
|
|---|
